NEW YORK – Genomics England is working with Sano Genetics and Zetta Genomics to develop a new software tool that will allow genomics research project participants with rare diseases to better self-report information and receive updates back.
The tool, set to be introduced next year, could also find application in other indications such as cancer. Sano Genetics aims to eventually make the finished platform available to its customers worldwide.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.